DEVELOPMENT OF THE COMPOSITION AND TECHNOLOGY OF CAPSULES CONTAINING VITIS VINIFERA L. LEAF RED EXTRACT DRY

Relevance. Development of dosage forms for the treatment of chronic venous insufficiency is an actual task of pharmaceutical technology due to the high prevalence of this disease. The extract has antioxidant, capillary-strengthening, anti-sclerotic, cardiovascular and anti-inflammatory effects. The aim of the study was to develop the composition and technology of hard gelatin capsules containing Vitis vinifera L. red leaves dry extract to ex-pand the range of domestic drugs with a venotonic effect. Objects of research: Vitis vinifera L. red leaves dry extract. Excipients: corn starch CleanSet 03703 (Cargill, the Netherlands), dextran Emdex (Dex-trates-JRS Pharma), lactose 80M (Lactochem Crystals, the Netherlands), microcrystalline cellulose MCC-101 (JRS Pharma, Germany), calcium stearate (Himmed, Russia), Aerosil A380 (GOST 14922-77). Results. The composition and production technology of capsules containing Vitis vinifera L. red leaves dry extract are substantiated. The quality indica-tors of Vitis vinifera L. red leaves dry extract in dosage form — capsules — were determined: appearance, uniformity of capsule mass, disintegration of capsules, authenticity, quantitative content of the sum of phenolic compounds in terms of rutin. All quality indicators comply with the requirements of the draft regulatory documentation “Vitis vinifera L. red leaves dry extract, 180 mg capsule”. Conclusion. Based on the results obtained, the composition of the capsules was developed: Vitis vinifera L. red leaves dry extract, corn starch, aero-sil, calcium stearate. The developed composition made it possible to obtain a mass for encapsulation by simply mixing the ingredients, followed by filling hard gelatin capsules. Capsules with Vitis vinifera L. red leaves dry extract expand the range of medicines for the prevention and treatment of chronic venous insufficiency.